Search Result |
Top |
| Entry | Name | Name(TN) | Disease |
|---|---|---|---|
| D00213 |
Fusidate sodium (USAN) Sodium fusidate (JP18) |
Fucidin leo (TN) | |
| D01764 | Diflucortolone valerate (JP18) | Afusona (TN) | |
| D04281 | Fusidic acid (USAN/INN) | ||
| D04715 |
Levoleucovorin calcium (USAN) Calcium levofolinate (INN) Levofolinate calcium (JAN) |
Fusilev (TN) |
Osteosarcoma [DS:H00036] Colorectal cancer [DS:H00020] |
| D05877 |
Sodium sulfate (USP) Sodium sulfate hydrate (JP18) Sodium sulfate decahydrate Natrium Sulfuricum Natrii Sulfus |
Sodium sulfate (TN) | |
| D06989 | Shofusan | ||
| D08000 |
Diethanolamine fusidate Fusidic acid diolamine |
Fucidin (TN) | |
| D08002 | Fusafungine (INN) | Locabiotal (TN) | |
| D08003 | Fusidic acid hemihydrate | Fucithalmic (TN) | |
| D08819 | Synthetic blood |
Blood for exchange transfusion (BET) (TN) Blood for exchange transfusion -leukocytes reduced (BET-LR) (TN) Irradiated blood for exchange transfusion (Ir-BET) (TN) Irradiated blood for exchange transfusion -leukocytes reduced (Ir-BET-LR) (TN) |
|
| D09091 |
Seijokentsuto Kufushokutsuto |
||
| D10761 |
Polatuzumab vedotin (USAN) Polatuzumab vedotin (genetical recombination) (JAN) Polatuzumab vedotin-piiq |
Polivy (TN) | Diffuse large B-cell lymphoma [DS:H02434] |
| D10813 |
Cerliponase alfa (USAN/INN) Cerliponase alfa (genetical recombination) (JAN) |
Brineura (TN) | Neuronal ceroid lipofuscinosis type 2 [DS:H00149] |
| D10926 | Entrectinib (JAN/USAN/INN) | Rozlytrek (TN) |
Non-small cell lung cancer (ROS1-positive) [DS:H00014] Solid tumors (NTRK gene fusion-positive) [DS:H02421] |
| D11138 | Larotrectinib sulfate (JAN/USAN) | Vitrakvi (TN) | Solid tumors (NTRK gene fusion-positive) [DS:H02421] |
| D11338 |
Loncastuximab tesirine (USAN) Loncastuximab tesirine (genetical recombination) (JAN) Loncastuximab tesirine-lpyl |
Zynlonta (TN) | Diffuse large B-cell lymphoma not otherwise specified [DS:H02434] |
| D11358 |
Tagraxofusp (USAN/INN) Tagraxofusp-erzs |
Elzonris (TN) | |
| D11393 | Rituximab and hyaluronidase | Rituxan hycela (TN) |
Follicular lymphoma [DS:H01613] Diffuse large B-cell lymphoma [DS:H02434] Chronic lymphocytic leukemia [DS:H00005] |
| D11417 | Pemigatinib (JAN/USAN/INN) | Pemazyre (TN) |
Cholangiocarcinoma (FGFR2 fusion positive) [DS:H00046] Myeloid-lymphoid neoplasms (FGFR1 rearrangement) [DS:H01605 H01612 H02410 H00007 H00011 H01613 H01463 H00005 H01464 H01613 H01892 H00008 H00001 H00002] |
| D11601 |
Tafasitamab (USAN/INN) Tafasitamab (genetical recombination) (JAN) Tafasitamab-cxix |
Monjuvi (TN) Minjuvi (TN) |
Diffuse large B-cell lymphoma (CD19-directed) [DS:H02434] |
| D11611 | Infigratinib phosphate (USAN) | Truseltiq (TN) | Cholangiocarcinoma (FGFR2 fusion or other rearrangement) [DS:H00046] |
| D11712 | Pralsetinib (USAN/INN) | Gavreto (TN) |
Non-small cell lung cancer (RET fusion positive) [DS:H00014] Medullary thyroid cancer (RET mutant) [DS:H01592] Thyroid cancer (RET fusion positive) [DS:H00032] |
| D11713 | Selpercatinib (JAN/USAN/INN) | Retevmo (TN) |
Non-small cell lung cancer (RET fusion positive) [DS:H00014] Medullary thyroid cancer (RET mutant) [DS:H01592] Thyroid cancer (RET fusion positive) [DS:H00032] |
| D11725 | Futibatinib (JAN/USAN/INN) | Lytgobi (TN) | Cholangiocarcinoma (FGFR2 gene fusion) [DS:H00046] |
| D11812 |
Pabinafusp alfa (genetical recombination) (JAN) Pabinafusp alfa (INN) |
Izcargo (TN) | |
| D11828 | Clervonafusp alfa (USAN/INN) | ||
| D11833 |
Glofitamab (USAN/INN) Glofitamab-gxbm |
Columvi (TN) |
Diffuse large B-cell lymphoma, not otherwise specified [DS:H02434] Follicular lymphoma [DS:H01613] |
| D11893 |
Bintrafusp alfa (USAN/INN) Bintrafusp alfa (genetical recombination) (JAN) |
||
| D11907 | Rozibafusp alfa (USAN/INN) | ||
| D11990 | Lisocabtagene maraleucel (USAN/INN) | Breyanzi (TN) |
Diffuse large B-cell lymphoma, not otherwise specified [DS:H02434] Follicular lymphoma [DS:H01613] |
| D12291 | Tovorafenib (USAN/INN) | Ojemda (TN) | Pediatric low-grade glioma (BRAF fusion or BRAF rearrangement, or BRAF V600 mutation positive) [DS:H00042] |
| D12296 |
Tebentafusp (USAN/INN) Tebentafusp-tebn |
Kimmtrak (TN) | Uveal melanoma (HLA-A*02:01-positive) [DS:H00038] |
| D12368 |
Epcoritamab (USAN/INN) Epcoritamab (genetical recombination) (JAN) Epcoritamab-bysp |
Epkinly (TN) Tepkinly (TN) |
Diffuse large B-cell lymphoma, not otherwise specified [DS:H02434] High-grade B-cell lymphoma [DS:H00008] |
| D12623 | Nanrilkefusp alfa (USAN/INN) | ||
| D12768 | Ficerafusp alfa (USAN) | ||
| D12791 | Eciskafusp alfa (USAN/INN) | ||
| D12806 | Tividenofusp alfa (USAN/INN) |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |